ketoconazole has been researched along with benzonidazole in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battista, MR; Brun, R; Calvet, CM; Cirilli, R; Costi, R; De Leo, A; De Vita, D; Di Marco, A; Di Santo, R; Faggi, C; Jennings, GK; Kaiser, M; Madia, VN; Mäser, P; Messore, A; Pepe, G; Pescatori, L; Podust, LM; Saccoliti, F; Scipione, L; Summa, V; Tudino, V | 1 |
| Aguirre, G; Boiani, L; Boiani, M; Castro, A; Cerecetto, H; Ferreira, A; González, M; Hernández, P; Maio, RD; Merlino, A; Porcal, W | 1 |
| Aguirre, G; Basombrío, MA; Boiani, L; Boiani, M; Campillo, NE; Castro, A; Cazzulo, JJ; Cerecetto, H; Chidichimo, A; Davies, C; González, M; Hernández, P; Krauth-Siegel, RL; Paez, JA; Porcal, W | 1 |
| Boiani, L; Boiani, M; Cazzulo, JJ; Cerecetto, H; Chidichimo, A; Ferreira, A; González, M; Hernández, P; Olea-Azar, C; Porcal, W | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Raether, W; Seidenath, H | 1 |
| Acuña, G; Brengues, C; Cuny, G; Labarca, J; Muñoz, S; Oddó, D; Saavedra, H; Sepúlveda, C; Solari, A; Veas, F | 1 |
| Araújo, MS; Brener, Z; Martins-Filho, OA; Pereira, ME | 1 |
| Dias Filho, BP; Kaneshima, EN; Nakamura, CV; Sarragiotto, MH; Silva, SO; Tonin, LT; Ueda-Nakamura, T; Valdez, RH; Yamada-Ogatta, SF; Yamauchi, LM | 1 |
| Lazarin-Bidóia, D; Nakamura, CV; Peron, F; Rodrigues-Filho, E; Silva, SO; Ud Din, Z; Ueda-Nakamura, T | 1 |
11 other study(ies) available for ketoconazole and benzonidazole
| Article | Year |
|---|---|
Design, Synthesis, and Biological Evaluation of New 1-(Aryl-1 H-pyrrolyl)(phenyl)methyl-1 H-imidazole Derivatives as Antiprotozoal Agents.
Topics: Animals; Antiprotozoal Agents; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Drug Evaluation, Preclinical; Humans; Imidazoles; Parasitic Sensitivity Tests; Trypanosoma | 2019 |
Second generation of 5-ethenylbenzofuroxan derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and structure-activity relationships.
Topics: Animals; Benzoxazoles; Cell Line; Cell Survival; Humans; Indicators and Reagents; Macrophages; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi | 2007 |
In vivo anti-Chagas vinylthio-, vinylsulfinyl-, and vinylsulfonylbenzofuroxan derivatives.
Topics: Animals; Antibodies, Protozoan; Benzoxazoles; Cell Line; Chagas Disease; Cysteine Endopeptidases; Female; Glutathione; Humans; Macrophages; Mice; Models, Molecular; NADH, NADPH Oxidoreductases; Oxidation-Reduction; Oxygen Consumption; Protozoan Proteins; Stereoisomerism; Structure-Activity Relationship; Sulfones; Trypanocidal Agents; Trypanosoma cruzi; Vinyl Compounds | 2007 |
New trypanocidal hybrid compounds from the association of hydrazone moieties and benzofuroxan heterocycle.
Topics: Animals; Benzoxazoles; Cysteine Endopeptidases; Glutathione; Hydrazones; Macrophages; Mice; Oxidative Stress; Protozoan Proteins; Spermidine; Trypanocidal Agents; Trypanosoma cruzi | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Ketoconazole and other potent antimycotic azoles exhibit pronounced activity against Trypanosoma cruzi, Plasmodium berghei and Entamoeba histolytica in vivo.
Topics: Amebiasis; Animals; Antifungal Agents; Chagas Disease; Entamoeba histolytica; Entamoebiasis; Ketoconazole; Malaria; Mice; Nitroimidazoles; Plasmodium berghei; Trypanosoma cruzi | 1984 |
Successful treatment of Trypanosoma cruzi encephalitis in a patient with hemophilia and AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Chagas Disease; Drug Therapy, Combination; Encephalitis; Fluconazole; Hemophilia A; Humans; Itraconazole; Ketoconazole; Male; Nitroimidazoles; Transfusion Reaction; Trypanocidal Agents | 1993 |
A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease.
Topics: Animals; Anti-Infective Agents; Antifungal Agents; Chagas Disease; Drug Combinations; Drug Synergism; Female; Ketoconazole; Mice; Nitroimidazoles; Ofloxacin; Time Factors; Trypanocidal Agents; Trypanosoma cruzi | 2000 |
In vitro and in vivo trypanocidal synergistic activity of N-butyl-1-(4-dimethylamino)phenyl-1,2,3,4-tetrahydro-β-carboline-3-carboxamide associated with benznidazole.
Topics: Amphotericin B; Animals; Body Weight; Carbolines; Cell Count; Cell Line; Chagas Disease; Drug Combinations; Drug Resistance; Drug Synergism; Haplorhini; Heart; Humans; Ketoconazole; Life Cycle Stages; Male; Mice; Mice, Inbred BALB C; Nitroimidazoles; Survival Rate; Trypanocidal Agents; Trypanosoma cruzi | 2012 |
Effects of (1
Topics: Chagas Disease; Drug Combinations; Drug Synergism; Fluconazole; Humans; Ketoconazole; Nitroimidazoles; Pentanones; Trypanosoma cruzi | 2017 |